Delivery Order SPE2DB22D1202-SPE2DB23FHPA2
- Not listed
- This federal contract award, valued at $11,203.29, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of AZELEX 20% cream, a pharmaceutical product, with a completion date of February 22, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $9,916.80 to supply AZELEX 20% Cream 30GM. The contract has a completion date of February 20, 2024 and was awarded on February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. This delivery order is part of a larger $999,999,999.00 indefinite delivery...
- This federal contract award, identified as SPE2DB22D3011|SPE2DB23FQ0HU, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,397.36, is for the delivery of AZELEX 20% Cream in 30g quantities. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 6, 2023. The award was made without any set-aside designation, indicating open competition....
- This federal contract award, valued at $1,439.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AZELEX 20% cream, a pharmaceutical product, and has a completion date of March 5, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,190.92 firm fixed-price delivery order is for the pharmaceutical product AZELEX 20% Cream, 30 grams. The contract has an ultimate completion date of July 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,909.71, is for the delivery of AZELEX 20% Cream, a pharmaceutical product, and was awarded on February 28, 2025, with a completion date of March 3, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type. The contract does not have a set-aside designation, indicating open...
- This federal contract award, with ID SPE2DB20D1100|SPE2DB25FB8L3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of the drug product Azelex 20% Cream 50GM. The contract has a firm fixed price of $1,034.35 and a completion date of April 22, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and this award is associated with the company's larger Indefinite...
- This federal contract award, valued at $1,209.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AZELEX 20% Cream, a topical pharmaceutical product, to support medical needs. This award is associated with an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug AZELEX 20% Cream in 30 gram containers. The $7,558.41 firm fixed price Delivery Order has a performance period ending on September 26, 2022 and was awarded on September 23, 2022. This contract is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,353.73 firm fixed-price delivery order is for the supply of AZELEX 20% cream, a pharmaceutical product, with a completion date of February 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB23FHPA2Delivery Order
This federal contract award is for the delivery of Azelex 20% cream (30g) to the Defense Logistics Agency (DLA), a defense agency. The $2,866.79 firm fixed-price delivery order was awarded on May 10, 2023 to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a completion date of May 11, 2023 and was not set aside for any specific business category. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems. The company holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 5/10/23 |